Results 201 to 210 of about 2,041,158 (244)

AI Chatbot Use and Disclosure for Mental Health Among US Adolescents and Young Adults. [PDF]

open access: yesJAMA Pediatr
McBain RK   +12 more
europepmc   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Enhancing epidemic forecast usability for policymakers: A global mixed-methods study. [PDF]

open access: yesPLOS Glob Public Health
Christen P   +12 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

International practices and variability in right heart echocardiography: results from the RVNet(Work) international survey. [PDF]

open access: yesEcho Res Pract
Magunia H   +15 more
europepmc   +1 more source

Strengthening frontline capacity for skin neglected tropical diseases: Findings from a global survey. [PDF]

open access: yesPLoS Negl Trop Dis
Anwar S   +8 more
europepmc   +1 more source

Pancreas Transplantation for Recipients with Type 2 Diabetes Mellitus: Results of an International Survey. [PDF]

open access: yesTransplant Direct
Fridell JA   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy